Wolverine Trading’s Aptose Biosciences, Inc. APTO Stock Holding History

Wolverine Trading’s Portfolio APTO Stock Details APTO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-33	Closed	-$35K	–	7192
2021 Q3	$35K	Buy	+33	New	+$41.3K	﹤0.01%	6072

Other funds holding APTO

DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return

SMH

Sanders Morris Harris Houston, Texas $172M AUM 22.54% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SPC

Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return

Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PAWC

P.A.W. Capital Greenwich, Connecticut $88.2M AUM 25.13% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wolverine Trading's APTO Position: Q4 2021 in Review

Wolverine Trading sold out of Aptose Biosciences, Inc. (APTO) in Q4 2021, closing a stake of 33 shares — an estimated $35K sold.

Wolverine Trading first reported a position in APTO in Q3 2021 and held it in 1 quarter. The position peaked at $35K in Q3 2021. 58 funds tracked by Wall St. Rank hold APTO as of Q4 2021.

Wolverine Trading reported no remaining Aptose Biosciences, Inc. position as of Q4 2021 after selling out during the quarter.
Wolverine Trading sold 33 Aptose Biosciences, Inc. shares in Q4 2021, an estimated $35K.
Wolverine Trading first reported a position in Aptose Biosciences, Inc. in Q3 2021 and held it in 1 quarter.
Wolverine Trading's Aptose Biosciences, Inc. position peaked at $35K in Q3 2021.
58 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q4 2021.

Based on Wolverine Trading's 13F filing for Q4 2021, filed 14 Feb 2022.